Related Experiment Videos
Medication adherence trends with statins
Michelle A Huser1, Tamara S Evans, Val Berger
1Butler University COPHS, Indianapolis, Indiana, USA.
Advances in Therapy
|July 16, 2005
Summary
Patient adherence to statin therapy for dyslipidemia is low, with persistence declining over time. Interventions by healthcare providers are crucial for improving compliance and reducing cardiac event risk.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Dyslipidemia increases cardiac event risk.
- Lipid-lowering medications, particularly statins, are effective but adherence is a challenge.
- Many patients fail to achieve lipid goals due to poor medication adherence.
Purpose of the Study:
- To assess adherence to statin therapy in patients with dyslipidemia.
- To identify factors influencing statin adherence and persistence.
- To evaluate the impact of adherence on achieving lipid goals.
Main Methods:
- Pharmacy records of 562 patients were screened; 140 were included after applying a washout rule.
- Key metrics calculated: length of therapy, persistence, medication possession ratio (MPR), and median gap between prescriptions.
- Analysis included demographic factors (age, sex) and specific statin types.
Main Results:
- Overall statin persistence declined from 56% at 9 months to 35% at 12 months.
- Persistence was lower in women (18%) and younger patients (<65 years, 19%) compared to men (34%) and older patients (≥65 years, 41%).
- Median gap days between refills was 6.83; atorvastatin showed higher persistence (36%) than simvastatin (26%) or pravastatin (5%).
Conclusions:
- Adherence to statin therapy is suboptimal in patients with dyslipidemia.
- Personalized interventions by healthcare providers can significantly improve patient compliance.
- Improving statin adherence is essential for reducing cardiac event risk in high-risk populations.